与摄食相关的胃肠肽。
Gastrointestinal peptides in eating-related disorders.
机构信息
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.
出版信息
Physiol Behav. 2021 Sep 1;238:113456. doi: 10.1016/j.physbeh.2021.113456. Epub 2021 May 11.
Abstract
Food intake is tightly controlled by homeostatic signals sensitive to metabolic need for the regulation of body weight. This review focuses on the peripherally-secreted gastrointestinal peptides (i.e., ghrelin, cholecystokinin, glucagon-like peptide 1, and peptide tyrosine tyrosine) that contribute to the control of appetite and discusses how these peptides or the signals arising from their release are disrupted in eating-related disorders across the weight spectrum, namely anorexia nervosa, bulimia nervosa, and obesity, and whether they are normalized following weight restoration or weight loss treatment. Further, the role of gut peptides in the pathogenesis and treatment response in human weight conditions as identified by rodent models are discussed. Lastly, we review the incretin- and hormone-based pharmacotherapies available for the treatment of obesity and eating-related disorders.
摘要
食物摄入受到对体重调节的代谢需求敏感的体内平衡信号的严格控制。本综述重点介绍了外周分泌的胃肠肽（即胃饥饿素、胆囊收缩素、胰高血糖素样肽 1 和酪酪肽），它们有助于控制食欲，并讨论了这些肽或它们释放产生的信号在厌食症、神经性贪食症和肥胖症等各种与体重相关的疾病中的紊乱情况，以及它们在体重恢复或减肥治疗后是否恢复正常。此外，还讨论了通过啮齿动物模型确定的肠肽在人类体重状况的发病机制和治疗反应中的作用。最后，我们回顾了用于治疗肥胖症和与饮食相关障碍的基于肠促胰岛素和激素的药物疗法。
相似文献
1
Gastrointestinal peptides in eating-related disorders.与摄食相关的胃肠肽。
Physiol Behav. 2021 Sep 1;238:113456. doi: 10.1016/j.physbeh.2021.113456. Epub 2021 May 11.
2
Eating disorders and gastrointestinal peptides.进食障碍与胃肠道肽类
Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):42-9. doi: 10.1097/MED.0b013e328341e12b.
3
Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).胃饥饿素抑制肠道中的胆囊收缩素（CCK）、肽YY（PYY）和胰高血糖素样肽-1（GLP-1），并减弱CCK、PYY和GLP-1对金鱼（Carassius auratus）的厌食作用。
Horm Behav. 2017 Jul;93:62-71. doi: 10.1016/j.yhbeh.2017.05.004. Epub 2017 May 18.
4
Effects of intraduodenal infusion of the branched-chain amino acid leucine on ad libitum eating, gut motor and hormone functions, and glycemia in healthy men.十二指肠内输注支链氨基酸亮氨酸对健康男性随意进食、肠道运动和激素功能以及血糖的影响。
Am J Clin Nutr. 2015 Oct;102(4):820-7. doi: 10.3945/ajcn.115.114488. Epub 2015 Aug 19.
5
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome.超重且患有和未患有多囊卵巢综合征的女性减肥前后的餐后胃饥饿素、胆囊收缩素、肽YY及食欲情况
Am J Clin Nutr. 2007 Dec;86(6):1603-10. doi: 10.1093/ajcn/86.5.1603.
6
Appetite-related peptides in childhood and adolescence: role of ghrelin, PYY, and GLP-1.儿童和青少年时期与食欲相关的肽类：胃饥饿素、肽YY和胰高血糖素样肽-1的作用
Appl Physiol Nutr Metab. 2015 Nov;40(11):1089-99. doi: 10.1139/apnm-2015-0050. Epub 2015 Aug 6.
7
Changes in the Homeostatic Appetite System After Weight Loss Reflect a Normalization Toward a Lower Body Weight.体重减轻后，体内平衡食欲系统的变化反映了向较低体重的正常化。
J Clin Endocrinol Metab. 2020 Jul 1;105(7):e2538-46. doi: 10.1210/clinem/dgaa202.
8
Gut hormones and appetite control.肠道激素与食欲控制
Gastroenterology. 2007 May;132(6):2116-30. doi: 10.1053/j.gastro.2007.03.048.
9
Gut hormones as peripheral anti obesity targets.肠道激素作为外周抗肥胖靶点。
Curr Drug Targets CNS Neurol Disord. 2004 Oct;3(5):379-88. doi: 10.2174/1568007043336950.
10
Gut hormones and appetite control.肠道激素与食欲控制。
Oral Dis. 2009 Jan;15(1):18-26. doi: 10.1111/j.1601-0825.2008.01492.x. Epub 2008 Oct 17.
引用本文的文献
1
Naringenin Decreases Retroperitoneal Adiposity and Improves Metabolic Parameters in a Rat Model of Western Diet-Induced Obesity.柚皮素可减少西方饮食诱导的肥胖大鼠模型的腹膜后脂肪堆积并改善代谢参数。
Metabolites. 2025 Feb 8;15(2):109. doi: 10.3390/metabo15020109.
2
Anorexia nervosa in children and adolescents: an early detection of risk factors.儿童和青少年神经性厌食症：危险因素的早期发现。
Ital J Pediatr. 2024 Oct 26;50(1):221. doi: 10.1186/s13052-024-01796-6.
3
Avoidant restrictive food intake disorder: recent advances in neurobiology and treatment.回避性限制性食物摄入障碍：神经生物学与治疗的最新进展
J Eat Disord. 2024 Jun 7;12(1):74. doi: 10.1186/s40337-024-01021-z.
4
Could Naringenin Participate as a Regulator of Obesity and Satiety?柚皮苷能否作为肥胖和饱腹感的调节剂？
Molecules. 2023 Feb 2;28(3):1450. doi: 10.3390/molecules28031450.
5
Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.饮食失调的精神和医学共病：文献快速综述的结果
J Eat Disord. 2022 Sep 5;10(1):132. doi: 10.1186/s40337-022-00654-2.
6
Investigating relationships between post-prandial gut hormone responses and taste liking ratings prior to and following bariatric surgery: a pilot study.研究肥胖症手术前后餐后肠道激素反应与味觉喜好评分之间的关系：一项初步研究。
Int J Obes (Lond). 2022 Dec;46(12):2114-2119. doi: 10.1038/s41366-022-01214-z. Epub 2022 Aug 31.
7
Introduction to ingestive behavior research across the generations (society for the study of ingestive behavior collection 2020).跨代摄食行为研究导论（摄食行为研究协会2020年论文集）
Physiol Behav. 2021 Nov 1;241:113561. doi: 10.1016/j.physbeh.2021.113561. Epub 2021 Aug 19.
本文引用的文献
1
Taste-related reward is associated with weight loss following bariatric surgery.与减重手术后体重减轻相关的是与味觉相关的奖励。
J Clin Invest. 2020 Aug 3;130(8):4370-4381. doi: 10.1172/JCI137772.
2
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study.度拉糖肽可减少伴有暴饮暴食症的2型糖尿病患者的暴饮暴食发作：一项试点研究。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):289-292. doi: 10.1016/j.dsx.2020.03.009. Epub 2020 Mar 31.
3
Gastric bypass in female rats lowers concentrated sugar solution intake and preference without affecting brief-access licking after long-term sugar exposure.在长期接触糖后，雌性大鼠的胃旁路手术会降低高浓度糖水的摄入和偏好，而不会影响短暂接触舔食。
Am J Physiol Regul Integr Comp Physiol. 2020 May 1;318(5):R870-R885. doi: 10.1152/ajpregu.00240.2019. Epub 2020 Feb 21.
4
Gastric Bypass Improves Obesity and Glucose Tolerance Independent of Gastric Pouch Size.胃旁路手术改善肥胖和葡萄糖耐量与胃囊大小无关。
Obes Surg. 2020 May;30(5):1635-1641. doi: 10.1007/s11695-020-04403-9.
5
GLP-1 and PYY reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats.GLP-1 和 PYY 在饮食诱导肥胖大鼠 Roux-en-Y 胃旁路手术后相加性地降低高脂肪食物偏好。
Surg Obes Relat Dis. 2019 Sep;15(9):1483-1492. doi: 10.1016/j.soard.2019.04.008. Epub 2019 Apr 16.
6
LEAP2 changes with body mass and food intake in humans and mice.LEAP2 在人体和小鼠中随体重和食物摄入而变化。
J Clin Invest. 2019 Sep 3;129(9):3909-3923. doi: 10.1172/JCI125332.
7
Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years.过去 10 年中，肠激素在抗肥胖药物研发方面的新方法。
Expert Opin Drug Discov. 2019 Nov;14(11):1151-1159. doi: 10.1080/17460441.2019.1646243. Epub 2019 Jul 29.
8
Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs.长效 CCK 类似物 NN9056 可降低肥胖哥廷根小型猪的食物摄入量和体重。
Int J Obes (Lond). 2020 Feb;44(2):447-456. doi: 10.1038/s41366-019-0386-0. Epub 2019 Jun 7.
9
Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.GLP-1R 和 Y2R 联合缺失不会改变高脂肪饮食诱导的肥胖的进展或对 RYGB 手术的反应。
Mol Metab. 2019 Jul;25:64-72. doi: 10.1016/j.molmet.2019.05.004. Epub 2019 May 9.
10
Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making.神经性厌食症患者和健康对照者的神经心理学表现与食欲调节激素之间的关联：Ghrelin 作为决策的中介可能起作用。
Mol Cell Endocrinol. 2019 Nov 1;497:110441. doi: 10.1016/j.mce.2019.04.021. Epub 2019 May 20.
Zotero 插件